SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-10-252297
Filing Date
2010-11-08
Accepted
2010-11-08 17:14:31
Documents
1
Group Members
INDEX VENTURES III (DELAWARE) L.P.INDEX VENTURES III (JERSEY) L.P.INDEX VENTURES III PARELLEL ENTREPRENEUR FUND (JERSEY) L.P.YUCCA PARTNERS L.P. JERSEY BRANCH

Document Format Files

Seq Description Document Type Size
1 SC 13D dsc13d.htm SC 13D 178129
  Complete submission text file 0001193125-10-252297.txt   180341
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85739 | Film No.: 101173281
SIC: 2834 Pharmaceutical Preparations

Mailing Address NO. 1 SEATON PLACE ST. HELIER Y9 JE 8YJ
Business Address NO. 1 SEATON PLACE ST. HELIER Y9 JE 8YJ 441534605643
Index Venture Associates III Ltd (Filed by) CIK: 0001503683 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13D